Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.

Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Mikovits JA.

Science. 2011 Oct 14;334(6053):176. doi: 10.1126/science.334.6053.176-a. No abstract available.

PMID:
21998366
2.

Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.

Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, Peterson DL, Ruscetti SK, Bagni RK, Petrow-Sadowski C, Gold B, Dean M, Silverman RH, Mikovits JA.

Science. 2009 Oct 23;326(5952):585-9. doi: 10.1126/science.1179052. Epub 2009 Oct 8. Erratum in: Science. 2011 Oct 14;334(6053):176. Retraction in: Alberts B. Science. 2011 Dec 23;334(6063):1636.

3.

The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Jones KS, Huang YK, Chevalier SA, Afonso PV, Petrow-Sadowski C, Bertolette DC, Gessain A, Ruscetti FW, Mahieux R.

J Virol. 2009 May;83(10):5244-55. doi: 10.1128/JVI.02285-08. Epub 2009 Mar 11.

4.

HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C.

Blood. 2009 May 21;113(21):5176-85. doi: 10.1182/blood-2008-04-150342. Epub 2009 Mar 6.

5.

Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW.

Nat Med. 2008 Apr;14(4):429-36. doi: 10.1038/nm1745. Epub 2008 Mar 23.

PMID:
18376405
6.
7.

Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.

Jones KS, Fugo K, Petrow-Sadowski C, Huang Y, Bertolette DC, Lisinski I, Cushman SW, Jacobson S, Ruscetti FW.

J Virol. 2006 Sep;80(17):8291-302.

8.

Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.

Jones KS, Petrow-Sadowski C, Bertolette DC, Huang Y, Ruscetti FW.

J Virol. 2005 Oct;79(20):12692-702.

9.

Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.

Jones KS, Akel S, Petrow-Sadowski C, Huang Y, Bertolette DC, Ruscetti FW.

J Immunol. 2005 Apr 1;174(7):4262-70.

10.

Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.

Taub DD, Mikovits JA, Nilsson G, Schaffer EM, Key ML, Petrow-Sadowski C, Ruscetti FW.

Cell Immunol. 2004 Aug;230(2):65-80.

PMID:
15598422
12.

Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.

Nath MD, Ruscetti FW, Petrow-Sadowski C, Jones KS.

Blood. 2003 Apr 15;101(8):3085-92. Epub 2002 Dec 27.

13.
14.

Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation.

Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW.

J Virol. 2001 Oct;75(20):9753-61.

Supplemental Content

Loading ...
Support Center